Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication October 14, 2002
- Accepted for publication December 9, 2002
- Published online April 1, 2003.
Copyright & Usage
© 2003 American Society of Nephrology
Author Information
View Abstract
Statistics from Altmetric.com
Article usage
Cited By...
Additive Effect of ACE Inhibition and Angiotensin II Receptor Blockade in Type I Diabetic Patients with Diabetic Nephropathy
Jump to section
More in this TOC Section
Cited By...
- Physiology of the Renal Interstitium
- Potassium Handling with Dual Renin-Angiotensin System Inhibition in Diabetic Nephropathy
- Recurrence of Secondary Glomerular Disease after Renal Transplantation
- Effects of Additive Therapy With Spironolactone on Proteinuria in Diabetic Patients Already on ACE Inhibitor or ARB Therapy: Results of a Randomized, Placebo-Controlled, Double-Blind, Crossover Trial
- Microalbuminuria in Type 2 Diabetes and Hypertension: A marker, treatment target, or innocent bystander?
- Are Two Better Than One? Angiotensin-Converting Enzyme Inhibitors Plus Angiotensin Receptor Blockers for Reducing Blood Pressure and Proteinuria in Kidney Disease
- Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: A Randomized Controlled Study of Benazepril and Losartan in Chronic Renal Insufficiency
- Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial
- Dual Blockade of the Renin-Angiotensin System in the Progression of Renal Disease: The Need for More Clinical Trials
- Progression of Renal Disease: Renoprotective Specificity of Renin-Angiotensin System Blockade
- ACE Inhibitor or Angiotensin II Receptor Antagonist Attenuates Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats
- Systematic Review of Combined Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blockade in Hypertension
- Long-Term Dual Blockade With Candesartan and Lisinopril in Hypertensive Patients With Diabetes: The CALM II study
- Recent advances in diabetic nephropathy